COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction

Cardiovasc Res. 2020 Aug 1;116(10):e132-e133. doi: 10.1093/cvr/cvaa140.

Jesús F Bermejo-Martin^{1

2

3}, Raquel Almansa^{1

2

3}, Antoni Torres^{3

4}, Milagros González-Rivera⁵, David J Kelvin^{6

7}

¹ Group for Biomedical Research in Sepsis (BioSepsis), Instituto de Investigación Biomédica de Salamanca (IBSAL), Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
² Hospital Universitario Río Hortega de Valladolid. Calle Dulzaina, 2, 47012 Valladolid, Spain.
³ Centro de Investigación Biomedica En Red-Enfermedades Respiratorias, Instituto de Salud Carlos III, Av. de Monforte de Lemos, 5, 28029, Madrid, Spain.
⁴ Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona (UB) - SGR 911 - Carrer de Villarroel, 170, 08036 Barcelona, Spain.
⁵ Biochemistry Service. Hospital General Universitario Gregorio Marañón, Calle del Dr. Esquerdo, 46, 28007 Madrid, Spain.
⁶ Department of Microbiology and Immunology, Canadian Centre for Vaccinology, Dalhousie University, Halifax, Nova Scotia, B3H 4R2, Canada.
⁷ Laboratory of Immunity Shantou University Medical College, 22 Xinling Rd, Jinping, Shantou, Guangdong, China.

No abstract available

Publication types